Skip to main content

Table 2 Main study endpoints in the two study treatment groups

From: Efficacy of frovatriptan in the acute treatment of menstrually related migraine: analysis of a double-blind, randomized, cross-over, multicenter, Italian, comparative study versus rizatriptan

 

Frovatriptan

Rizatriptan

p

Pain relief episodes at 2 h

25 (58)

27 (64)

NS

Pain free episodes at 2 h

15 (31)

20 (34)

NS

Pain relief episodes at 24 h

35 (81)

31 (74)

NS

Pain free episodes at 24 h

33 (67)

36 (61)

NS

Recurrent episodes at 24 h

5 (10)

19 (32)

<0.01

  1. Data are reported as absolute (n) and relative (%) frequency. P refers to the statistical significance of the difference between the two study drugs
Back to article page

The Journal of Headache and Pain

ISSN: 1129-2377

Contact us